Free Trial

IDEXX Laboratories (IDXX) SEC Filings & 10K Form

IDEXX Laboratories logo
$471.90 +0.52 (+0.11%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$471.84 -0.06 (-0.01%)
As of 05/2/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent IDEXX Laboratories SEC Filings

DateFilerForm TypeView
05/02/2025
3:19 PM
COLLINS Asha (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
3:11 PM
IDEXX Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
6:12 PM
Emerson Andrew (Reporting)
IDEXX Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2025
7:28 AM
IDEXX Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/18/2025
8:42 PM
Erickson Michael G (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:42 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
Hunt Nimrata (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Johnson Michael Perkins (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Lane Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
MAZELSKY JONATHAN JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:44 PM
IDEXX Laboratories (Issuer)
Underberg Sharon E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:44 PM
IDEXX Laboratories (Issuer)
MCKEON BRIAN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:52 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2025
3:08 PM
IDEXX Laboratories (Subject)
SZOSTAK M ANNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
4:00 PM
Erickson Michael G (Reporting)
IDEXX Laboratories (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
12/09/2024
6:32 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
4:00 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:36 PM
IDEXX Laboratories (Subject)
Vandebroek Sophie V. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
6:32 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:48 PM
IDEXX Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
6:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:47 AM
IDEXX Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:14 PM
IDEXX Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
12:23 PM
IDEXX Laboratories (Filer)
Form 8-K/A
10/31/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:18 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
3:20 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:36 PM
IDEXX Laboratories (Subject)
SZOSTAK M ANNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:20 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:03 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:00 PM
IDEXX Laboratories (Filer)
Form SD
Specialized Disclosure Report  
05/17/2024
2:49 PM
Claflin Bruce L. (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
6:00 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 PM
Britt Irene Chang (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 PM
Claflin Bruce L. (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 PM
COLLINS Asha (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

05/08/2024
6:01 PM
ESSIG STUART (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
Kingsley Lawrence D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
SAMAD SAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IDXX) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners